COMMUNIQUÉS West-GlobeNewswire

Leading Ophthalmologists to Discuss the Value of IRIDEX Solutions at AAO

23/10/2018 - 14:00

Glaucoma and Retina Specialists Will Discuss the Benefits of MicroPulse® Technology MOUNTAIN VIEW, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX), a leading provider of innovative laser [...]

Biotricity Extends Heart Rate Variability Research to Include Fetal and Maternal Applications

23/10/2018 - 14:00

Mobile Wireless Monitoring Solution with High Fidelity Metrics Could Make Non-Invasive Maternal/Fetal Monitoring a Reality REDWOOD CITY, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a [...]

Alder BioPharmaceuticals® Announces Positive Results From Pharmacokinetic Comparability Study for Eptinezumab

23/10/2018 - 14:00

BOTHELL, Wash., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Inovalon Clients Realize Significant Increases in CMS Star Ratings Compared to National Average For 5th Year In a Row

23/10/2018 - 13:55

Advanced Analytics and Data-Driven Capabilities Powered by the Inovalon ONE® Platform Support Meaningful Quality Outcomes Improvements BOWIE, Md., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq:INOV), a leading [...]

Arvinas to Present at Two Protein Degradation Conferences

23/10/2018 - 13:30

NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced it will be presenting at two upcoming [...]

Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results

23/10/2018 - 13:30

Call to be held on Monday, October 29th at 4:30 p.m. Eastern Time AUSTIN, Texas, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, announced today it will release [...]

Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study

23/10/2018 - 13:30

NORTHVALE, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Canada House Wellness Group Will Hold Annual General Meeting on October 30th

23/10/2018 - 13:30

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc (“Canada House” or the “Company”) (CSE: CHV) would like to [...]

KemPharm and twoXAR Announce Technology Collaboration to Develop Prodrug-Based Therapies for Multiple Indications

23/10/2018 - 13:30

Drug Development Approach Combines twoXAR’s Artificial-Intelligence-Driven Drug Discovery Technology with KemPharm’s LAT TM Prodrug Technology CORALVILLE, Iowa, Oct. 23, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: [...]

Selecta Biosciences Presents New Interim Data from Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at ACR 2018

23/10/2018 - 13:05

Interim analysis indicates serum uric acid (SUA) control has been maintained into months four and five with once monthly combination treatment, SUA control projected to be 66% at end of study period Patient imaging has [...]

IMV Inc. to Announce Third Quarter 2018 Financial Results and Host Earnings Call on November 2, 2018

23/10/2018 - 13:05

DARTMOUTH, Nova Scotia, Oct. 23, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical stage immunotherapy company, announced today that it will hold a conference call and [...]

Myriad Announces Publication of Foresight™ Carrier Screen Clinical Utility Study in Genetics in Medicine

23/10/2018 - 13:05

Large Study Demonstrates that Expanded Carrier Screening Informs Couples’ Reproductive Choices and Pregnancy Management SALT LAKE CITY, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global [...]

Resonant Releases Details of its Breakthrough XBAR Resonator Technology for 5G Mobile Devices

23/10/2018 - 13:05

GOLETA, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, today released [...]

Aptose to Release Third Quarter Ended September 30, 2018 Financial Results on November 6, 2018

23/10/2018 - 13:05

Conference Call to Be Held Wednesday, November 7, 2018 SAN DIEGO and TORONTO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage company developing highly differentiated [...]

Tonix Pharmaceuticals to Present at the Dawson James Securities Small Cap Growth Conference

23/10/2018 - 13:00

NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present and host [...]

Imprimis Pharmaceuticals’ Subsidiary Melt Pharmaceuticals Initiates Clinical Development Program for its Patented Non-Opioid and Non-Invasive MK Melt™ Conscious Sedation Drug Candidate

23/10/2018 - 13:00

FDA Grants Pre-IND Meeting; Two Investigator-led Studies on Melt Formulations to Commence in Q4 SAN DIEGO, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, a subsidiary of Imprimis Pharmaceuticals, Inc. (NASDAQ: [...]

Beyondspring Provides Operational Update and Second-Quarter 2018 Financial Results

23/10/2018 - 13:00

- Reported Top Line Positive Efficacy and Safety Data from Phase 2 Study 106 Evaluating Plinabulin in Combination With Neulasta for Chemotherapy-Induced Neutropenia (CIN) Prevention - On Track to Report Interim Data [...]

Intra-Cellular Therapies Announces Favorable Safety Profile for ITI-214 in a Phase 1/2 Clinical Trial in Patients with Parkinson’s Disease

23/10/2018 - 13:00

Results show ITI-214 is associated with clinical signs consistent with improvements in motor symptoms and dyskinesias NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) today [...]

CureVac Announces First Study Participant Enrolled in Phase I Clinical Trial Testing Prophylactic mRNA Rabies Vaccine

23/10/2018 - 13:00

Trial to provide first-in-human data for CureVac’s novel mRNA-based intramuscular rabies vaccine TÜBINGEN, Germany and BOSTON, Oct. 23, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company [...]